{"id":50360,"date":"2024-08-20T11:20:04","date_gmt":"2024-08-20T10:20:04","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=50360"},"modified":"2024-08-20T11:20:04","modified_gmt":"2024-08-20T10:20:04","slug":"rice-university-awarded-18m-to-advance-tumour-removal-technology","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/rice-university-awarded-18m-to-advance-tumour-removal-technology\/50360\/","title":{"rendered":"Rice University awarded $18m to advance tumour removal technology"},"content":{"rendered":"
The funding, which will be distributed over five years, will support the development of a new system to enhance the accuracy of tumour removal in breast, head and neck cancer.<\/p>\n
Rice University was among eight institutions chosen to receive a share of the $150 million in grants<\/a> announced earlier this week by the Biden-Harris administration.<\/p>\n This funding is part of the ongoing Cancer Moonshot initiative, which seeks to halve the cancer death rate by 2047.<\/p>\n The Rice and MD Anderson research team has developed a groundbreaking cancer pathology system called AccessPath, which addresses a significant challenge surgeons face: accurately identifying the margin where a tumour ends and healthy tissue begins.<\/p>\n Leveraging advanced technologies, including a high-resolution microscope and advanced artificial intelligence algorithms, AccessPath enables surgeons to determine in real-time whether they have completely removed a tumour during surgery<\/a>.<\/p>\n \u201cBecause of its low cost, high speed, and automated analysis, we believe AccessPath can revolutionise real-time surgical guidance, greatly expanding the range of hospitals able to provide accurate intraoperative tumour margin assessment and improving outcomes for all cancer surgery patients,\u201d explained Rebecca Richards-Kortum, a lead researcher on the project and director of the Rice360 Institute for Global Health Technologies.<\/p>\n According to ARPA-H, nearly two million Americans are diagnosed with cancer each year.<\/p>\n Given the complexity and high cost of cancer treatment, AccessPath offers a promising solution by reducing the number of repeat interventions, lowering cancer care costs and improving patient outcomes.<\/p>\n This cutting-edge innovation stems from a strategic partnership established this summer between Rice University and MD Anderson.<\/p>\nGroundbreaking tumour removal technology provides more accurate surgery<\/h3>\n
Life-changing healthcare research and innovation<\/h3>\n